[News18]News18 Daybreak | Bharat Biotech’s Covid Vaccine Gets Clearance for Phase III Trial; Barring a Few Govt Restores Existing Visas and Other Stories You Need to Watch Out For
Bharat Biotech's Covaxin Gets Clearance for Phase III Trial; Centre Sets Aside Rs 500 Bn for Immunisation: ReportCovaxin, an indigenously developed vaccine candidate by Bharat Biotech, has got clearance for phase three trial in India. A top source said that the trials will start in the first week of ...